Bio-Synthesis Expands Dye Labeling Licensing

Lewisville, TX, November 09, 2007 --(PR.com)-- Bio-Synthesis, Inc. is happy to announce that Biosearch Technologies of Novato, California, have extended Bio-Synthesis Inc, of Lewisville, Texas their line of Fluorescent dyes and quenchers for use in biomedical research applications. End users who source Biosearch dyes for any purpose other than non-commercial R&D applications will still be required to contact the Biosearch Technologies Licensing Department to obtain a Commercial Use License. These dyes are chemically coupled to synthetic oligonucleotides and provide an excellent means for non-radioactive detection of DNA targets. Bio-Synthesis Inc has been providing custom synthetic oligonucleotides to the biomedical research community worldwide since 1984

Bio-Synthesis Inc (BSI), headquartered in Lewisville, Texas is a leading biomedical manufacturer of custom peptide synthesis, polyclonal antibodies, bioconjugates, DNA oligomer, HLA/DNA typing, organic synthesis and a diverse number of bimolecular products for the biomedical/life science community worldwide. BSI's staff of highly experienced and qualified chemists, biologists and immunologists has reliably and consistently provided products and services to large pharmaceuticals and universities across the country that meet the most demanding requirements for quality, turnaround and expert technical support.

Bio-Synthesis Inc was the first commercial company providing DNA and peptides in 1984 and have assisted biomedical researchers (and published articles) in the design of complex bimolecular, of >600,000 peptides used in a variety of fields including but not limited to cancer, apoptosis, signal transduction, cell cycle regulation, genomic sequencing, microarrays, epitope mapping, and HLA typing. BSI specializes in custom peptide synthesis from small to large scale and can help design the optimal peptides for research needs at the most competitive price and the highest quality. BSI has capabilities to synthesize over 500 peptides simultaneously with over 22 years of experienced manufacturing. BSI believes their quality control and speed is unmatched in the industry. The organic synthesis divisions have successfully completed a number of projects with various biotechnology companies. Furthermore, Bio-Synthesis Inc. is accredited by the AABB (American Association of Blood Banks) to conduct human genetic analysis. Bio-Synthesis continues to be the worldwide leader for quality custom synthesis.

For more information, please call 1-800-227-0627.

###